Nasser, Jason
Mehravar, Sepideh
Pimentel, Mark
Lim, Jane
Mathur, Ruchi
Boustany, Antoine
Rezaie, Ali
Funding for this research was provided by:
Cedars-Sinai Medical Center
Article History
Received: 29 April 2024
Accepted: 21 June 2024
First Online: 13 July 2024
Declarations
:
: MP is a consultant for Ferring Pharmaceuticals, Inc, Salvo Health, Dieta Health, and Vivante Health, Inc has received grant support from Bausch Health, and has equity in Gemelli Biotech, Dieta Health, Salvo Health, Vivante Health, and Good LFE. RM has equity in Gemelli Biotech and Good LFE. AR is a consultant/speaker for Bausch Health and has equity in Gemelli Biotech and Good LFE. Cedars-Sinai has licensing agreements with Hobbs Medical and Gemelli Biotech. All other authors report no conflicts of interest.